Vir Biotechnology (VIR) Return on Equity [ROE] (2019 - 2026)
Vir Biotechnology (VIR) posted Return on Equity [ROE] of -19.67% for Q3 2026, up 37.64 percentage points from -57.31% a year earlier and up 8.36 percentage points from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Return on Equity [ROE] (2019 - 2026) Analysis & Trends
For FY2025, Vir Biotechnology's Return on Equity [ROE] came in at -45.73%, down 7.64 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four consecutive years, though with a five-year change of +6.63 percentage points (FY2020 to FY2025).
- In prior years, Vir Biotechnology's Return on Equity [ROE] was -38.09% in FY2024 (-4.55 pp), -33.54% in FY2023 (-62.93 pp), 29.39% in FY2022 (-19.81 pp) and 49.20% in FY2021 (+101.56 pp).
- The Q3 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q2 2023.
- On a year-over-year basis, Return on Equity [ROE] increased in two of the last eight quarters, with an average year-over-year change of -1.95 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2022, with a gain of 127.93 percentage points; the weakest was Q3 2023, with a drop of 90.19 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -28.04% (Q2 2026), -56.11% (Q1 2026) and -56.10% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Vir Biotechnology | 2.23 Bn | 313.19 Mn | 188,000.00 | -19.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -19.67% |
| Jun 30, 2026 | -28.04% |
| Mar 31, 2026 | -56.11% |
| Dec 31, 2025 | -56.10% |
| Sep 30, 2025 | -57.31% |
| Jun 30, 2025 | -55.26% |
| Mar 31, 2025 | -52.65% |
| Dec 31, 2024 | -43.66% |
| Sep 30, 2024 | -39.89% |
| Jun 30, 2024 | -32.41% |
| Mar 31, 2024 | -34.39% |
| Dec 31, 2023 | -37.68% |
| Sep 30, 2023 | -34.47% |
| Jun 30, 2023 | -13.86% |
| Mar 31, 2023 | -7.10% |
| Dec 31, 2022 | 24.40% |
| Sep 30, 2022 | 55.72% |
| Jun 30, 2022 | 54.53% |
| Mar 31, 2022 | 70.85% |
| Dec 31, 2021 | 45.80% |
API Access
Vir Biotechnology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();